PAK4 and breast carcinoma: To this end, siRNA-mediated knock-down of PAK4 as well as the GNE-2861 compound caused decreased ERα protein levels in both MCF-7 and T47D human breast cancer cell lines (Figure 4A and Supplementary Figure S3A).